Aging-related genes in mesenchymal stem cells: A mini-review

Gerontology

Volumn 59, Issue 6, 2013, Pages 557-563

  Yu, Kyung Rok ^a   Kang, Kyung Sun ^a  

^a Seoul National University   (South Korea)

Author keywords

Aging; DNA methyltransferase; High mobility group A2; Histone deacetylase; Lamin A; Mesenchymal stem cells; P16INK4A; ZMPSTE24

Indexed keywords

BUTYRIC ACID; CD11B ANTIGEN; CD14 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLINE; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; GAMMA INTERFERON; GRANZYME B; HIGH MOBILITY GROUP A2 PROTEIN; HISTONE ACETYLTRANSFERASE; HISTONE H3; HISTONE H4; HLA DR ANTIGEN; LAMIN A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; HISTONE DEACETYLASE;

AGING; CELL ACTIVATION; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CHEMOTAXIS; CPG ISLAND; DNA DAMAGE; DNA METHYLATION; DOUBLE STRANDED DNA BREAK; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HISTONE ACETYLATION; HUMAN; IMMUNOGENICITY; IMMUNOMODULATION; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; MICROENVIRONMENT; NATURAL KILLER CELL; NEURAL STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; SENESCENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; UMBILICAL CORD BLOOD; CELL AGING; CELL NUCLEUS; EPIGENETICS; GENE CONTROL; MOLECULAR INTERACTION; NONHUMAN; NUCLEAR LAMINA; SIGNAL TRANSDUCTION;

AGING; ANIMALS; DNA MODIFICATION METHYLASES; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENES, P16; HISTONE DEACETYLASES; HMGA2 PROTEIN; HUMANS; LAMIN TYPE A; MESENCHYMAL STROMAL CELLS; SIGNAL TRANSDUCTION;

EID: 84887037283     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000353857     Document Type: Review

References (30)

1. Hayflick L: How and Why We Age, ed 1. New York, Ballantine Books, 1994.
2. Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT, Dombkowski DM, Cheng T, De-Pinho RA, Sharpless NE, Scadden DT: Stemcell ageing modified by the cyclin-dependent kinase inhibitor p16ink4a. Nature 2006; 443: 421-426. (Pubitemid 44477274)
3. Kode JA, Mukherjee S, Joglekar MV, Hardikar AA: Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 2009; 11: 377-391.
4. Schu S, Nosov M, O'Flynn L, Shaw G, Treacy O, Barry F, Murphy M, O'Brien T, Ritter T: Immunogenicity of allogeneic mesenchymal stem cells. J Cell Mol Med 2012; 16: 2094-2103.
5. El Haddad N, Heathcote D, Moore R, Yang S, Azzi J, Mfarrej B, Atkinson M, Sayegh MH, Lee JS, Ashton-Rickardt PG, Abdi R: Mesenchymal stem cells express serine protease inhibitor to evade the host immune response. Blood 2011; 117: 1176-1183.
6. Muraglia A, Cancedda R, Quarto R: Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000; 113: 1161-1166. (Pubitemid 30229533)
7. Sperka T, Wang J, Rudolph KL: DNA damage checkpoints in stem cells, ageing and cancer. Nat Rev Mol Cell Biol 2012; 13: 579-590.
8. Sengupta N, Seto E: Regulation of histone deacetylase activities. J Cell Biochem 2004; 93: 57-67.
9. Karantzali E, Schulz H, Hummel O, Hubner N, Hatzopoulos A, Kretsovali A: Histone deacetylase inhibition accelerates the early events of stem cell differentiation: transcriptomic and epigenetic analysis. Genome Biol 2008; 9:R65.
10. Ware CB, Wang L, Mecham BH, Shen L, Nelson AM, Bar M, Lamba DA, Dauphin DS, Buckingham B, Askari B, Lim R, Tewari M, Gartler SM, Issa JP, Pavlidis P, Duan Z, Blau CA: Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells. Cell Stem Cell 2009; 4: 359-369.
11. Li Z, Liu C, Xie Z, Song P, Zhao RC, Guo L, Liu Z, Wu Y: Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PloS One 2011; 6:e20526.
12. Jung JW, Lee S, Seo MS, Park SB, Kurtz A, Kang SK, Kang KS: Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3. Cell Mol Life Sci 2010; 67: 1165-1176.
13. Lee S, Jung JW, Park SB, Roh K, Lee SY, Kim JH, Kang SK, Kang KS: Histone deacetylase regulates high mobility group A2-targeting microRNAs in human cord blood-derived multipotent stem cell aging. Cell Mol Life Sci 2011; 68: 325-336.
14. Jaenisch R, Bird A: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33(suppl):245-254. (Pubitemid 36278835)
15. Cervoni N, Szyf M: Demethylase activity is directed by histone acetylation. J Biol Chem 2001; 276: 40778-40787.
16. So AY, Jung JW, Lee S, Kim HS, Kang KS: DNA methyltransferase controls stem cell aging by regulating BMI1 and EZH2 through micrornas. PloS One 2011; 6:e19503.
17. Rayess H, Wang MB, Srivatsan ES: Cellular senescence and tumor suppressor gene p16. Int J Cancer 2012; 130: 1715-1725.
18. Shibata KR, Aoyama T, Shima Y, Fukiage K, Otsuka S, Furu M, Kohno Y, Ito K, Fujibayashi S, Neo M, Nakayama T, Nakamura T, Toguchida J: Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells 2007; 25: 2371-2382. (Pubitemid 47480497)
19. Zheng Y, He L, Wan Y, Song J: H3K9meenhanced DNA hypermethylation of the p16INK4a gene: an epigenetic signature for spontaneous transformation of rat mesenchymal stem cells. Stem Cells Dev 2013; 22: 256-267.
20. Gu Z, Cao X, Jiang J, Li L, Da Z, Liu H, Cheng C: Upregulation of p16INK4A promotes cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients. Cell Signal 2012; 24: 2307-2314.
21. Grosschedl R, Giese K, Pagel J: HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet 1994; 10: 94-100. (Pubitemid 24075089)
22. Yu KR, Park SB, Jung JW, Seo MS, Hong IS, Kim HS, Seo Y, Kang TW, Lee JY, Kurtz A, Kang KS: HMGA2 regulates the in vitro aging and proliferation of human umbilical cord blood-derived stromal cells through the mTOR/p70S6K signaling pathway. Stem Cell Res 2013; 10: 156-165.
23. Nishino J, Kim I, Chada K, Morrison SJ: Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf expression. Cell 2008; 135: 227-239.
24. Iglesias-Bartolome R, Patel V, Cotrim A, Leelahavanichkul K, Molinolo AA, Mitchell JB, Gutkind JS: mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. Cell Stem Cell 2012; 11: 401-414.
25. Hutchison CJ, Worman HJ: A-type lamins: guardians of the soma? Nat Cell Biol 2004; 6: 1062-1067. (Pubitemid 39468007)
26. Liu B, Wang J, Chan KM, Tjia WM, Deng W, Guan X, Huang JD, Li KM, Chau PY, Chen DJ, Pei D, Pendas AM, Cadinanos J, Lopez-Otin C, Tse HF, Hutchison C, Chen J, Cao Y, Cheah KS, Tryggvason K, Zhou Z: Genomic instability in laminopathy-based premature aging. Nat Med 2005; 11: 780-785. (Pubitemid 41021211)
27. Cao K, Blair CD, Faddah DA, Kieckhaefer JE, Olive M, Erdos MR, Nabel EG, Collins FS: Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts. J Clin Invest 2011; 121: 2833-2844.
28. Scaffidi P, Misteli T: Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol 2008; 10: 452-459.
29. Corrigan DP, Kuszczak D, Rusinol AE, Thewke DP, Hrycyna CA, Michaelis S, Sinensky MS: Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24. Biochem J 2005; 387: 129-138. (Pubitemid 40524082)
30. Ragnauth CD, Warren DT, Liu Y, McNair R, Tajsic T, Figg N, Shroff R, Skepper J, Shanahan CM: Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation 2010; 121: 2200-2210.